Ted W. Love - Sep 27, 2022 Form 4 Insider Report for Global Blood Therapeutics, Inc. (GBT)

Role
President and CEO, Director
Signature
/s/ Miguel Carrillo, Attorney-in-Fact
Stock symbol
GBT
Transactions as of
Sep 27, 2022
Transactions value $
$299,972
Form type
4
Date filed
9/29/2022, 08:45 PM
Previous filing
Sep 6, 2022
Next filing
Oct 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBT Common Stock Gift $0 -221K -27.16% $0.00 593K Sep 9, 2022 Direct
transaction GBT Common Stock Gift $0 -35.3K -5.95% $0.00 558K Sep 13, 2022 Direct
transaction GBT Common Stock Gift $0 +17.7K +17.3% $0.00 120K Sep 13, 2022 By Trust 1
transaction GBT Common Stock Gift $0 +17.7K +17.3% $0.00 120K Sep 13, 2022 By Trust 2
transaction GBT Common Stock Options Exercise $300K +18.3K +3.28% $16.40* 576K Sep 27, 2022 Direct
holding GBT Common Stock 102K Sep 27, 2022 By Trust 3
holding GBT Common Stock 2.5K Sep 27, 2022 By Daughter
holding GBT Common Stock 2.5K Sep 27, 2022 By Daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBT Stock Option (Right to Buy) Options Exercise $0 -18.3K -13.77% $0.00 115K Sep 27, 2022 Common Stock 18.3K $16.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Common Stock underlying the option vested in equal quarterly installments over 16 quarters from January 17, 2017 through January 17, 2021.